Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Insulin Articles

Type 1 Glucose Production Pill on the Horizon
What are your thoughts on insulin pumps?
Community’s Positive Effect on Diabetes Management
At the Crossroads, I Choose Insulin
Reduced Insulin May Prevent Exercise-Related Hypoglycemia
An Interview With My Husband, Rick
Living With Type 1 Diabetes
Smaller, Lighter OmniPod Earns FDA Approval
We’re Not Bad, We’re Human
The Penalty of Not Being Able to Afford Care Is Too Expensive
Diabetes Health Reference Charts
Insulin Pen Needles Reference Guide (PDF)
Lancing Devices Reference Guide (PDF)
Lancing Devices Reference Guide (PDF)
Syringes Reference Guide (PDF)
Insulin Pumps Reference Guide (PDF)
Mail Order Reference Guide (PDF)
Insulin Reference Guide (PDF)
Infusion Sets Reference Guide (PDF)
Mail Order Reference Guide (PDF)
See All Charts…
Insulin Archives
Browse the Insulin Archives
Subscribe to the Medications RSS Feed
Print | Email | Share | Comments (0)

Two New Oral Insulins on the Horizon


Nov 1, 2001

First Phase Test Trials Are Successful

Emisphere Technologies Inc., of Tarrytown, New Jersey announced the results of three phase I studies for two new medications for the oral delivery of insulin. Representatives, who presented the data at Investor Day In New York City and released a written statement on September 7, said the trials showed that the drugs were successfully absorbed from the gastrointestinal tract and significantly reduced blood glucose levels in study subjects.

"We are extremely excited about the data from all three studies," said Alan C. Moses, MD, chief medical officer and senior vice president, Joslin Diabetes Center, during the presentation. "Besides demonstrating insulin absorption in the gastrointenstinal tract, the studies were able to demonstrate a reduction in blood sugar levels. If oral insulin can be developed successfully, it will provide patients with diabetes a highly desirable option for insulin delivery that can be used early in type 2 diabetes and that can be used in combination with a single long-acting injection of insulin in type 1 diabetes."

Categories: Blood Glucose, Blood Sugar, Diabetes, Diabetes, Insulin, Medications Research, Research, Type 1 Issues, Type 2 Issues

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Nov 1, 2001

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.